General - Press Releases

Date	Title	Company
26-Oct-2021	Axcella Therapeutics Launches Clinical Program to Develop Treatment for Patients with Long COVID	Businesswire
26-Oct-2021	Ionic Liquids Market, 2026 - ResearchAndMarkets.com	Businesswire
26-Oct-2021	Solasia and Nippon Kayaku Announce License Agreement in Japan for New Drug Candidate DARINAPARSIN (SP-02)	Businesswire
26-Oct-2021	Gilead and Merck Initiate Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Lenacapavir and Investigational Islatravir for HIV-1 Treatment in Virologically Suppressed Adults	Businesswire
26-Oct-2021	SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate Into Combination With Checkpoint Inhibitors	Businesswire
26-Oct-2021	Diverse Biotech Announces Its DBT-12733 Molecule Demonstrated to Be Up to 8,000 Times More Effective Than Temozolomide for Brain Cancer	Businesswire
26-Oct-2021	Tal Zaks Joins Strategic Advisory Board at Deep Genomics	Businesswire
26-Oct-2021	First Patient Dosed in Phase 2 Precision Medicine Study of Lenzilumab in Patients with Chronic Myelomonocytic Leukemia (CMML)	Businesswire
26-Oct-2021	Vizient Announces Milestone in Fight to End Drug Shortages: 100 Million Additional Units of Essential Medications Through Novaplus Enhanced Supply Program in Under Two Years	Businesswire
26-Oct-2021	H.I.G. BioHealth Partners Co-Leads a $52M Financing for Click Therapeutics	Businesswire
26-Oct-2021	Global Organ Transplant Diagnostics Market to Reach $9,663.0 Million by 2031 - ResearchAndMarkets.com	Businesswire
26-Oct-2021	Atamyo Therapeutics Submits CTA in Europe for ATA-100, Its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9	Businesswire
26-Oct-2021	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
26-Oct-2021	GHO Capital invests in Sanner Group, a leading global supplier of high-quality active packaging solutions and components for the Pharmaceutical, Diagnostic, Nutraceutical and MedTech industries	Businesswire
26-Oct-2021	TheraVet: First Patients Treated With BIOCERA-VET® Bone Surgery in the United States of America	Businesswire
26-Oct-2021	Moderna Announces Memorandum of Understanding to Supply up to 110 Million Doses of Its COVID-19 Vaccine to the African Union	Businesswire
25-Oct-2021	EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BMRN	Businesswire
25-Oct-2021	Moderna Announces European Medicines Agency’s Committee for Medicinal Products for Human Use Recommends Booster Dose of Moderna’s COVID-19 Vaccine in the European Union	Businesswire
25-Oct-2021	Medpace Holdings, Inc. Reports Third Quarter 2021 Results	Businesswire
25-Oct-2021	Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results	Businesswire